Summary
- Current Price
- As of today, HIMS price is $28.61, down -0.56% on
- Current Price All-Time High
- HIMS price is currently -60.80% below its historical high of $72.98 set on
- Market Cap
- HIMS current market cap is $7B, down -37.26% year-over-year
- Revenue
- HIMS current annual revenue is $2.35B, up +59.00% year-over-year
- Next Earnings
- The next earnings release for HIMS is on
Profile
| Metric | Value |
|---|---|
| Full Name | Hims & Hers Health, Inc. |
| Ticker | NYSE: HIMS |
| Exchange | NYSE |
| Sector | Healthcare |
| Industry | Specialty & Generic Drug Manufacturers |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | hims.com |
| Employees | 1,637 |
Key Metrics
| Metric | Value | Date |
|---|---|---|
| Price | $28.61 | |
| Price, 1D Change | -0.56% | |
| Market Cap | $7B | |
| - | ||
| PE Ratio | - | |
| Beta | 2.83 | |
| Revenue | $2.35B | |
| Revenue, 1Y Change | +59.00% | |
| EPS | $0.51 | |
| EPS, 1Y Change | -3.74% |
Chart
SUGGESTED SERIES
Events
| Metric | Value | Date |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | OAC | |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Value | Date |
|---|---|---|
| EPS | $0.51 | |
| EPS Estimate | -$0.41 | N/A |
| EPS Est. Change | -180.85% | N/A |
| Revenue | $2.35B | |
| Revenue Estimate | $3.21B | N/A |
| Revenue Est. Change | +36.55% | N/A |
| Current Price | $28.61 | |
| Price Target | $30.00 | - |
| Price Tgt. Change | +4.86% | - |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $0.85 | $0.53 | -37.20% | |
| $0.47 | $0.51 | +8.95% | |
| -$0.41 | N/A | -180.85% | |
| $0.58 | N/A | +13.53% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $1.46B | $1.48B | +0.92% | |
| $2.35B | $2.35B | +0.03% | |
| $3.21B | N/A | +36.55% | |
| $4.00B | N/A | +70.45% |
🔒 Log In To Unlock Full Data
Performance
| Metric | Value | Date |
|---|---|---|
| Price, 1Y | -39.30% | |
| Price, 3Y | +301.83% | |
| Market Cap, 1Y | -37.26% | |
| Market Cap, 3Y | +344.75% | |
| Revenue, 1Y | +59.00% | |
| Revenue, 3Y | +345.54% | |
| EPS, 1Y | -3.74% | |
| EPS, 3Y | +259.55% |
🔒 Log In To Unlock Full Data
Technicals
| Metric | Value | Date |
|---|---|---|
| Current Price | $28.61 | |
| SMA 200 | $29.17 | |
| SMA 50 | $31.75 | |
| EMA 200 | - | |
| EMA 50 | - | |
| - | ||
| Beta | 2.83 | |
| ATR | $2.33 | |
| 14-Day RSI | 42.73 | |
| 10-Day Volatility | 85.84% |
Dividends
| Metric | Value | Date |
|---|---|---|
| - | N/A | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Value | Date |
|---|---|---|
| Revenue | $2.35B | |
| EPS | $0.51 | |
| Gross Profit | $1.39B | |
| Gross Margin | 59.31% | |
| Operating Income | $121.69M | |
| Operating Margin | 5.18% | |
| Net Income | $128.37M | |
| Net Margin | 5.47% | |
| EBITDA | $176.19M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Value | Date |
|---|---|---|
| Debt To Equity | 2.07 | |
| 1.90 | ||
| 1.61 | ||
| - | ||
| 2 | ||
| 3.89 |
Valuations
| Metric | Value | Date |
|---|---|---|
| PE Ratio | - | |
| 2.59 | ||
| 20.60 | ||
| 85.37 | ||
| - | N/A |
Balance Sheet
| Metric | Value | Date |
|---|---|---|
| Book Value | $540.93M | |
| $577.49M | ||
| $2.15B | ||
| $767.64M | ||
| $1.61B | ||
| $404.43M | ||
| Total Debt | $1.12B | |
| $4.84M | ||
| $143.28M |
Expenses
| Metric | Value | Date |
|---|---|---|
| $2.22B | ||
| $1.27B | ||
| $955.21M | ||
| $0.00 | ||
| $54.50M | ||
| $0.00 | ||
| -$4.44M |
Cash Flow
| Metric | Value | Date |
|---|---|---|
| $300.01M | ||
| -$1.02B | ||
| $729.62M | ||
| Capex | $242.59M | |
| $57.42M |
Recent analyst updates
| Metric | Value | Date |
|---|---|---|
| TD Cowen | → | |
| Needham | → | |
| Morgan Stanley | → | |
| Deutsche Bank | → | |
| Citigroup | → | |
| B of A Securities | → | |
| Truist Securities | → | |
| Citigroup | → | |
| B of A Securities | → | |
| Canaccord Genuity | → |
Analyst sentiment
Institutional ownership
No data
Screeners with HIMS
FAQ
- What is the ticker symbol for Hims & Hers Health, Inc.?
- The ticker symbol for Hims & Hers Health, Inc. is NYSE:HIMS
- Does Hims & Hers Health, Inc. pay dividends?
- No, Hims & Hers Health, Inc. does not pay dividends
- What sector is Hims & Hers Health, Inc. in?
- Hims & Hers Health, Inc. is in the Healthcare sector
- What industry is Hims & Hers Health, Inc. in?
- Hims & Hers Health, Inc. is in the Specialty & Generic Drug Manufacturers industry
- What country is Hims & Hers Health, Inc. based in?
- Hims & Hers Health, Inc. is headquartered in United States
- When did Hims & Hers Health, Inc. go public?
- Hims & Hers Health, Inc. initial public offering (IPO) was on September 13, 2019
- Is Hims & Hers Health, Inc. in the S&P 500?
- No, Hims & Hers Health, Inc. is not included in the S&P 500 index
- Is Hims & Hers Health, Inc. in the NASDAQ 100?
- No, Hims & Hers Health, Inc. is not included in the NASDAQ 100 index
- Is Hims & Hers Health, Inc. in the Dow Jones?
- No, Hims & Hers Health, Inc. is not included in the Dow Jones index
- When was Hims & Hers Health, Inc. last earnings report?
- Hims & Hers Health, Inc.'s most recent earnings report was on August 10, 2026
- When does Hims & Hers Health, Inc. report earnings?
- The next expected earnings date for Hims & Hers Health, Inc. is November 9, 2026
Data Sources & References
- HIMS Official Website www.hims.com
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1773751/000177375126000022/0001773751-26-000022-index.htm
- HIMS Profile on Yahoo Finance finance.yahoo.com/quote/HIMS
- HIMS Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/hims
